Alimera Sciences Announces Presentation Of Data From The 12-Month Interim Readout Of The Human PK ILUVIEN™ Study At ARVO 2009 An

Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commerciali... [more]

View complete Press Release article